...
首页> 外文期刊>Nuclear Medicine Communications >Retrospective study of coronary uptake of 18F-fluorodeoxyglucose in association with calcification and coronary artery disease: a preliminary study.
【24h】

Retrospective study of coronary uptake of 18F-fluorodeoxyglucose in association with calcification and coronary artery disease: a preliminary study.

机译:回顾性研究18F-氟脱氧葡萄糖与钙化和冠状动脉疾病相关的冠状动脉摄取:一项初步研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To determine whether focal 18F-fluorodeoxyglucose (FDG) uptake could be detected along the course of coronary arteries in patients with known coronary artery disease (CAD) and/or coronary artery calcification (CAC) by PET/computed tomography (CT) using a new patient preparation protocol that reduces background myocardial FDG uptake. MATERIALS AND METHODS: In this retrospective, Health Insurance Portability and Accountability Act-compliant study approved by our institutional internal review board, 60 FDG-PET/CT studies performed for noncardiac indications were reviewed and CAC and focal FDG uptake were determined. Cardiac histories were obtained. Age range was 21-88 years (64+/-16 years); 35 women/25 men; six had CAD documented by myocardial perfusion imaging, cardiac catheterization, or history of percutaneous coronary intervention or coronary artery bypass grafting. Chi-square probabilities were calculated. RESULTS: Fifteen of the 60 patients studied showed focal FDG uptake along the courseof coronary arteries; fourteen of these showed significant CAC scores and four had documented CAD. The concordance of focal FDG coronary artery uptake was 58% with CAC, 77% with cardiac history, and 90% with extracardiac vascular focal FDG uptake. There were 20 focal FDG and coronary artery lesions in 15 patients and 11 of the 20 colocalized with calcification. No preferred anatomic location was found (junction, end of calcification or along coronary artery). CONCLUSION: This limited retrospective study shows that with a new patient preparation to reduce high FDG uptake by the myocardium on PET/CT scans, foci of increased FDG cardiac uptake can be seen in association with CAC and in patients with a history of CAD. These results provide initial evidence that it may be possible to use FDG-PET/CT to monitor sites of coronary plaque formation. Larger and invasive prospective studies will be necessary to fully determine the suitability of this technique for that purpose.
机译:目的:通过PET /计算机断层扫描(CT),确定已知冠状动脉疾病(CAD)和/或冠状动脉钙化(CAC)患者在冠状动脉的过程中是否可以检测到局灶性18F-氟脱氧葡萄糖(FDG)摄取减少背景心肌FDG摄取的新患者准备方案。材料和方法:在此回顾性研究中,我们的机构内部审查委员会批准了符合《健康保险携带与责任法案》的研究,对60例针对非心脏适应症的FDG-PET / CT研究进行了审查,并确定了CAC和FDG的局部摄取。获得心脏历史。年龄范围为21-88岁(64 +/- 16岁); 35名女性/ 25名男性; 6例通过心肌灌注显像,心脏导管插入术,经皮冠状动脉介入治疗或冠状动脉搭桥术的病史记录了CAD。计算卡方概率。结果:60例患者中有15例在冠状动脉过程中表现出局灶性FDG摄取。其中14个显示出显着的CAC分数,另外4个记录了CAD。 CAC的局灶性FDG冠状动脉摄取一致性为58%,心脏病史为77%,心外血管局灶性FDG摄取率为90%。 15例患者中有20例局灶性FDG和冠状动脉病变,而20例中有11例伴钙化。未发现优选的解剖位置(交界处,钙化终点或沿冠状动脉)。结论:这项有限的回顾性研究表明,采用新的患者制剂减少PET / CT扫描显示的心肌对FDG的高摄入量,可以发现与CAC和有CAD史的患者相关的FDG心脏摄取量增加。这些结果提供了使用FDG-PET / CT监测冠状动脉斑块形成部位的初步证据。为了全面确定该技术是否适合该目的,将需要进行更大范围的侵入性前瞻性研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号